Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.79 |
| ▸ | MAPT | P10636 | 1/20 | 0.79 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8211629 | 0.98 | SMN1; SMN2 (0.75) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL8211498 | 0.96 | SMN1; SMN2 (0.72) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL3739691 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL28498331 | 0.96 | SMN1; SMN2 (0.71) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| Hydrochloric Acid SCHEMBL4011611 | 0.95 | SMN1; SMN2 (0.75) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL29427509 | 0.89 | TDP1 (1.00) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL231092 | 0.89 | TDP1 (1.00) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL8508012 | 0.88 | SMN1; SMN2 (0.61) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL10609540 | 0.87 | TDP1 (0.96) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 | |
| SCHEMBL26521138 | 0.86 | SMN1; SMN2 (0.72) | SMN1; SMN2MAPTLIN28ATDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11649222-B2 | Compounds | UNIVERSITETET I OSLO (NO) | 2023-05-16 | — | — | US | disclosed |
| US-11649222-B2 | Compounds | UNIVERSITETET I OSLO (NO) | 2023-05-16 | — | — | US | disclosed |
| US-11649222-B2 | Compounds | UNIVERSITETET I OSLO (NO) | 2023-05-16 | — | — | US | disclosed |
| EP-3978488-A1 | ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | Universitetet I Oslo (NO) | 2022-04-06 | — | — | EP | disclosed |
| EP-3978488-A1 | ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | Universitetet I Oslo (NO) | 2022-04-06 | — | — | EP | disclosed |
| US-20210221791-A1 | COMPOUNDS | UNIVERSITETET I OSLO (NO) | 2021-07-22 | — | — | US | disclosed |
| US-20210221791-A1 | COMPOUNDS | UNIVERSITETET I OSLO (NO) | 2021-07-22 | — | — | US | disclosed |
| EP-3497095-B1 | ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | UNIV OSLO (NO) | 2021-07-14 | — | — | EP | disclosed |
| EP-3497095-B1 | ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | UNIV OSLO (NO) | 2021-07-14 | — | — | EP | disclosed |
| US-10961223-B2 | Compounds | UNIVERSITETET I OSLO (NO) | 2021-03-30 | — | — | US | disclosed |
| US-10961223-B2 | Compounds | UNIVERSITETET I OSLO (NO) | 2021-03-30 | — | — | US | disclosed |
| US-20190284167-A1 | COMPOUNDS | UNIVERSITETET I OSLO (NO) | 2019-09-19 | — | — | US | disclosed |
| US-20190284167-A1 | COMPOUNDS | UNIVERSITETET I OSLO (NO) | 2019-09-19 | — | — | US | disclosed |
| WO-2018033719-A1 | COMPOUNDS | UNIVERSITETET I OSLO (NO) | 2018-02-22 | — | — | WO | disclosed |
| EP-1008645-B1 | Detergent bleaching compositions | UNILEVER PLC (GB) | 2004-07-21 | — | — | EP | disclosed |
| US-6165963-A | Detergent bleaching composition comprising pentadentate ligand derivatives | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1008645-A1 | Detergent bleaching compositions | UNILEVER PLC (GB) | 2000-06-14 | — | — | EP | disclosed |
| WO-2000027975-A1 | DETERGENT BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2000-05-18 | — | — | WO | disclosed |
| US-6022490-A | FOR ACTIVATING PEROXY BLEACH | LEVER BROTHERS COMPANY (US) | 2000-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649222-B2 | Compounds | SLC30A6, SLC39A11, SLC39A3 | SMN1; SMN2 3219/4885MAPT 4706/4885LIN28A 3489/4885 |
| US-10961223-B2 | Compounds | SLC30A6, SLC39A11, SLC30A5 | SMN1; SMN2 3067/4885MAPT 4738/4885LIN28A 3418/4885 |
| US-20190284167-A1 | COMPOUNDS | SLC30A6, SLC39A11, SLC30A5 | SMN1; SMN2 3067/4885MAPT 4738/4885LIN28A 3418/4885 |
| US-20210221791-A1 | COMPOUNDS | SLC30A6, SLC30A5, SLC39A11 | SMN1; SMN2 2917/4885MAPT 4862/4885LIN28A 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.